Flow Cytometry Market

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents & Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Labs, Pharma-Biotech), Application, and Region - Global Forecast to 2023

Report Code: BT 6015 Oct, 2019, by marketsandmarkets.com
Updated date -

[233 Pages Report] The flow cytometry market is projected to grow from an estimated USD 3.7 billion in 2018 to USD 5.4 billion by 2023, at a CAGR of 8.1% during the forecast period. Market growth is largely driven by factors such as technological advancements in flow cytometers, the increasing adoption of flow cytometry techniques in research activities and clinical trials, growing focus on immunology and immuno-oncology research, high incidence and prevalence of HIV-AIDS and cancer, and the increasing availability of novel application-specific flow cytometry products. The growing market penetration in emerging countries, growth in stem cell research, adoption of recombinant DNA technology for antibody production, and evolution of tandem flow cytometry technologies are expected to present a wide range of growth opportunities for market players.

Flow Cytometry Market

To get more details on this report, Download PDF Brochure

Market Dynamics

Increasing adoption of flow cytometry techniques in research and academia

Flow cytometry has emerged as a key tool for safety and exploratory purposes during the drug discovery and development processes, right from preclinical trials to target identification and throughput screening. This is because of its technological ability to analyze a large number of particles in a short period of time to provide statistically robust information about the cell population. This, coupled with its multi-parametric approach, is facilitating the adoption of flow cytometry in drug discovery and development processes in the pharmaceutical and biopharmaceutical industry. Moreover, Biomarker research has become an integral part of drug discovery and development as biomarker data provides valuable evidence to guide clinical decisions, assess the pharmacodynamics of drugs, and support drug filings with regulatory bodies, thereby increasing the market value of a drug as well as accelerating its approval process. Flow cytometry is widely used in biomarker research as well, to monitor the development and differentiation of cell populations, evaluate target engagement and biomarker expression in cells, and assess cell functions and signaling events.

A significant number of clinical trials are being conducted across the globe with an aim to develop novel therapeutics to address the rising disease burden. The growing number of clinical trials is augmented by the availability of public as well as private funding for various clinical trial projects. For instance,

  • In September 2018, the US FDA awarded 12 new clinical trials a grant of ~USD 18 million over a period of four years. These clinical trials are aimed at developing products for patients with rare diseases (including primary sclerosing cholangitis, Stargardt disease, Cushing disease, acute myeloid leukemia, and graft versus host disease, among others) (Source: US FDA).
  • In 2016, the Global Clinical Trials Fund (UK) launched a dedicated fund with an upper limit of USD 662,185 (GBP 500,000) to support clinical trials across the world related to the testing of new experimental drugs and existing drugs developed for dementia.

Therefore, increasing number of clinical trials coupled with the adoption of flow cytometry for various research applications is driving the growth of this market. In addition, the development of advanced flow cytometry products has brought increased automation, ease of use, and more accurate analysis for various research and clinical uses. This trend has facilitated increased accessibility to various applications of flow cytometry to research laboratories of all sizes. Initiatives taken by governments, key market players, and academic institutions in terms of grants and funding to increase the adoption of flow cytometry in life science-related research activities are also contributing to the growth of the market. Listed below are some recent developments undertaken during 2015-2018 in this regard:

  • NIH, in 2018, announced a Shared Instrumentation for Animal Research (SIFAR) Grant Programme allocating USD 6.0 million. This utilizes flow cytometry principles essentially in animal research in fields related to biomedical research, neurophysiology, immunology, cardiology, and developmental biology.
  • In November 2017, NanoCellect Biomedical Inc. (US) received a total amount of USD 3.0 million from the National Institute of General Medical Sciences (US) and the National Institute of Drug Abuse (US), under the Small Business Innovation Research Program (SBIR). The company plans to use the funding for its R&D activities related to WOLF Cell Sorter and N1 Single-cell Dispenser.
  • In August 2017, a researcher (Mr. Jason Moffat) at the Terrence Donnelly Centre for Cellular and Biomolecular Research (Canada) received a funding amount of ~USD 110,000 from the Government of Canada. This funding will be utilized for the development of high-throughput flow cytometry capacity for functional genomics, proteomics, and biologics.
  • In August 2017, Kinetic River Corp., a flow cytometry instrumentation developer, received a Small Business Innovation Research (SBIR) grant totaling about USD 225,000 from the National Institutes of Health (NIH). This funding helps in developing Kinetic River’s Arno-cell analysis technology.
  • In July 2016, a researcher (Mr. Joseph Tario Jr.) at the Roswell Park Cancer Institute (US) received a one-year grant of USD 105,907 from the International Myeloma Foundation (US). The grant was aimed to characterize a flow cytometric assay designed to detect minimal residual disease in bone marrow samples in patients with multiple myeloma.

Therefore, such funding and grants help researchers to accelerate research and development activities and help in the expansion of research infrastructure, thereby driving the demand for flow cytometry products.

Significant product costs

Majority of target end users (such as clinical laboratories, large research facilities, and pharmaceutical companies) require significant number of flow cytometry instruments to simultaneously carry out multiple research studies. This leads to a significant increase in the capital cost associated with the procurement and maintenance of these devices. Academic and research laboratories find it difficult to afford such instruments due to restricted budgets. In addition, maintenance costs and several other indirect expenses result in an overall increase in the total cost of ownership of these instruments. Thus, the high product installation cost and other related expenditure hinders the optimal adoption of flow cytometry instruments in both clinical and research applications, especially in emerging nations. Also, flow cytometry instruments are equipped with advanced features and functionalities and are thus high-priced instruments; whereas, flow cytometry-based cell sorters are even more expensive than cell analyzers. For instance,

  • As of December 2018, the average installed price of a flow cytometer in the US varies between USD 35,000 and USD 300,000
  • CyFlow Cube 6 from Sysmex-Partec costs around USD 35,000 while Merck Millipore’s Guava EasyCyte costs between USD 55,000 to USD 65,000, as of 2018
  • S3 cell sorter from Bio-Rad Laboratories is priced at USD 150,000, while BD’s FACSJazz costs around USD 240,000, as of 2018
  • Low-range cell sorter is priced between USD 90,000 and USD 200,000; whereas high-end cell sorters are priced above USD 300,000 as of 2018

Additionally, the demand for high-priced flow cytometry instruments and reagents is restricted due to end users’ preference for alternative affordable cell and genomic analysis techniques (such as microscopy, spectroscopy, PCR, and NGS), especially among individual researchers, small CROs, and emerging pharmaceutical & biotechnology companies. Thus, significant product pricing coupled with availability of alternative techniques are poised to retrain the optimal revenue growth of flow cytometry market during the study period.

Growing market presence in emerging countries

Emerging countries (such as China, India, South Korea, Brazil, and Mexico) offer significant growth opportunities to major players operating in the global flow cytometry market. This can be attributed to the increasing research initiatives across key countries coupled with low regulatory barriers, continuous improvement in healthcare infrastructure, growing patient population, rising healthcare expenditure, and strengthening distribution network of market leaders in these regions. Moreover, regulatory policies in the Asia Pacific region are more adaptive and business-friendly due to less stringent regulations and data requirements. This, along with the increasing competition in mature markets, has further propelled key players in the flow cytometry market to focus on the emerging countries. For instance, China is witnessed with continuously strengthening healthcare infrastructure, fast-paced economy, rising domestic demand, and public-private initiatives those support various research activities. Similarly, the Indian market is also reported with increasing prevalence of target diseases and fast-growing life science research industry coupled with a shift towards advanced analytical equipment and laboratory workflow automation.

Thus, in order to leverage the growth opportunities, prominent players present in the global flow cytometry market are increasingly focusing to enhance their presence in emerging countries and to expand their regional product offerings by pursuing various growth strategies including expansions, partnerships, and collaborations, among others. For instance, in February 2016, Luminex Corporation (US) collaborated with the University of Sγo Paulo (Brazil) to validate the MultiFLEX Mosquito-borne Panel, a multi-analyte Zika virus assay developed by Luminex’s partner GenArraytion, Inc. The MultiFLEX Mosquito-borne panel is a qualitative nucleic acid assay that utilizes the Luminex 100/200, a flexible analyzer based on the principles of flow cytometry, or MAGPIX instrument to simultaneously test for a broad array of the most common mosquito-borne disease agents, including Zika virus (4 genetic targets), Chikungunya virus, Dengue virus (DEN-1, DEN-2, DEN-3 and DEN-4), West Nile virus, Yellow Fever virus, and Plasmodium falciparum. Similarly, in November 2015, Beckman Coulter (a subsidiary of Danaher Corporation, US) entered into a distribution agreement with IncellDx, Inc. (US). Under this agreement, Beckman Coulter will focus on the marketing of flow cytometry products to clinical researchers located in China, Hong Kong, and Taiwan that are researching human papillomavirus (HPV) and cancer.

Therefore, growth potential offered by emerging countries coupled with strengthening product portfolio and distribution channel of key players are poised to offer renewed growth opportunities for stakeholders active in flow cytometry industry during the study period.

Inadequate research infrastructure across emerging countries

Flow cytometry techniques are widely used in life science research. Proper research infrastructural facilities, including skilled users, core facilities, financial support, and basic research laboratories, are a key prerequisite for the use of flow cytometry techniques for research. However, emerging countries in Asia (such as India, Indonesia, and Philippines), Middle East (such as Oman, Iraq, and UAE), and Africa lack the required infrastructural facilities. According to the Directorate of Economics and Statistics, India, of the 4,168 private laboratories in the state of Kerala (India), only 7% have the National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation or ISO certification.

Thus, the dearth of adequate infrastructural facilities poses a challenge for the growth prospects of the flow cytometry market in emerging countries.

By technology, the bead-based flow cytometry segment is expected to grow at the highest rate during the forecast period

By technology, the global market is categorized into cell-based and bead-based flow cytometry. The bead-based technology segment is expected to grow at the highest CAGR during the forecast period, owing to the procedural advantages offered by this technology over other cell-based technology (such as ELISA and western blot), including its capacity to detect multiple analytes, high reproducibility, stability, and speed.

By product and service, the reagents and consumables segment is expected to account for the largest share of the flow cytometry market in 2018

On the basis of product and service, the market is categorized into reagents and consumables; instruments; services; software; and accessories. The reagents and consumables segment is expected to dominate the market. Factors such as the development and commercialization of high-quality application-specific reagents and assays and the continuous requirement of flow cytometry reagents by end users are expected to drive the growth of the reagents and consumables market in the coming years.

Asia Pacific is expected to grow at the fastest rate in the flow cytometry market during the forecast period

Geographically, this market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2018, the global market is expected to be dominated by North America, followed by Europe. However, the Asia Pacific is expected to witness the fastest growth during the forecast period owing to the participation of China, India, Japan, and South Korea in flow cytometry-based research; expansion of research infrastructure; and increasing public-private initiative aimed towards boosting advance research practices in this region.

Flow Cytometry Market

To get more details on this report, Request FREE Sample

Key Market Players

Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMιrieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US) and Apogee Flow Systems Ltd. (UK).

Becton, Dickinson and Company (US) is one of the leading players in the global flow cytometry industry. Its broad portfolio of flow cytometry products and well-established presence in across the globe is the key factor accounting for its large share in this market. The company has adopted both organic and inorganic growth strategies such as product launches, agreements, partnerships, collaborations, and expansions in order to maintain its top position in the field of flow cytometry. The company is also focused on providing training and conducting workshops to increase the adoption of its products.

Scope of the Report

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Value (USD)

Segments covered

Technology, Product and Services, Application, End User and Region

Geographies covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East and Africa

Companies covered
(15 major players)

Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMιrieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US) and Apogee Flow Systems Ltd. (UK)

This research report categorizes the market based on technology, product and service, application, end user, and region.

Global Flow Cytometry Market, by Technology

  • Cell-based flow cytometry
  • Bead-based flow cytometry

Global Flow Cytometry Market, by Product and Service

  • Reagents and consumables
  • Instruments
    • Cell analyzers
      • High-range
      • Mid-range
      • Low-range
    • Cell sorters
      • High-range
      • Mid-range
      • Low-range
  • Services
  • Software
  • Accessories

Global Flow Cytometry Market, by Application

  • Research applications
    • Pharmaceutical and biotechnology
      • Drug discovery
      • Stem cell research
      • In vitro toxicity testing
    • Immunology
    • Cell sorting
    • Apoptosis
    • Cell cycle analysis
    • Cell viability
    • Cell counting
    • Other research applications
  • Clinical applications
    • Cancer
    • Hematology
    • Immunodeficiency diseases
    • Organ transplantation
    • Other clinical applications
  • Industrial applications

Global Flow Cytometry Market, by End User

  • Academic & research institutes
  • Hospitals & clinical testing laboratories
  • Pharmaceutical & biotechnology companies

Global flow cytometry Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of the Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (Rest of LATAM)
  • Middle East and Africa

Recent Developments

  • In 2018, Becton, Dickinson and Company (US) launched BD FACSymphony S6 High Parameter Cell Sorter.
  • In 2018, Agilent Technologies, Inc. (US) entered into an agreement to acquire ACEA Biosciences Inc. (US) to expand its global revenue base, product portfolio, and strengthen its market share.
  • In 2018, Merck KGaA (Germany) launched the CellStream benchtop flow cytometer system.

Key questions addressed by the report:

  • What are the growth opportunities related to the adoption of flow cytometry across major regions in the future?
  • Where will technological advancements take the industry in the mid- to long-term?
  • What are the various research and clinical applications wherein flow cytometry finds a high adoption rate?
  • What are the new trends and advancements in flow cytometry?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 24)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Study Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency Used for the Study
    1.5 Stakeholders

2 Research Methodology (Page No. - 27)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Estimation Methodology
           2.2.1 Revenue Mapping-Based Market Estimation
           2.2.2 Usage-Based Market Estimation
           2.2.3 Primary Research Validation
    2.3 Data Triangulation Methodology
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 36)

4 Premium Insights (Page No. - 41)
    4.1 Flow Cytometry: Market Overview
    4.2 Market, By Product & Service, 2018 vs 2023
    4.3 Market, By Application, 2018 vs 2023 (USD Million)
    4.4 Market, By End User, 2018 vs 2023
    4.5 Geographical Snapshot of the Market

5 Market Overview (Page No. - 45)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Technological Advancements
                    5.2.1.2 Increasing Adoption of Flow Cytometry Techniques in Research and Academia
                    5.2.1.3 Growing Public-Private Initiatives in the Field of Immunology and Immuno-Oncology Researches
                    5.2.1.4 Rising Global Incidence and Prevalence of Hiv/Aids and Cancer
                    5.2.1.5 Increased Availability of Application-Specific Products
           5.2.2 Restraints
                    5.2.2.1 Significant Product Costs
                    5.2.2.2 Dearth of Well-Trained and Skilled Professionals
           5.2.3 Opportunities
                    5.2.3.1 Growing Market Presence in Emerging Countries
                    5.2.3.2 Evolving Pipeline for Stem Cell Research
                    5.2.3.3 Adoption of Recombinant Dna Technology for Antibody Production
                    5.2.3.4 Advent of Tandem Flow Cytometry Technologies
           5.2.4 Challenges
                    5.2.4.1 Inadequate Research Infrastructure Across Emerging Countries
                    5.2.4.2 Complexities Related to Reagent Development
                    5.2.4.3 Limited Purchasing Power of Majority of End Users in Emerging Countries
    5.3 Regulatory Challenges
           5.3.1 Stringent Fda Requirements
           5.3.2 Stringent Analyte-Specific Reagent (ASR) Rule
           5.3.3 Lack of Well-Defined Validation Protocols for Cell-Based Assays
           5.3.4 Absence of Established Laboratory-Developed Test (LDT) Guidelines on Cell-Based Fluorescence Assays
           5.3.5 Greater Global Recognition for Ivd–Ce Mark Approvals
    5.4 U.S. Reimbursement Scenario

6 Flow Cytometry Market, By Technology (Page No. - 58)
    6.1 Introduction
    6.2 Cell-Based Flow Cytometry
           6.2.1 Cell-Based Technologies to Dominate the Global Market Till 2023
    6.3 Bead-Based Flow Cytometry
           6.3.1 Procedural Advantages to Drive the Market Growth for Bead-Based Flow Cytometry Segment

7 Flow Cytometry Market, By Product & Service (Page No. - 63)
    7.1 Introduction
    7.2 Reagents and Consumables
           7.2.1 Flow Cytometry Reagents and Consumables Market Split, By Application
           7.2.2 Flow Cytometry Reagents and Consumables Market Split, By Research Application
           7.2.3 Flow Cytometry Reagents and Consumables Market Split, By Clinical Application
           7.2.4 Flow Cytometry Reagents and Consumables Market Split, By End User
    7.3 Flow Cytometry Instruments
           7.3.1 Flow Cytometry Instruments Market Split, By Application
           7.3.2 Flow Cytometry Instruments Market Split, By Research Application
           7.3.3 Flow Cytometry Instruments Market Split, By Clinical Application
           7.3.4 Flow Cytometry Instruments Market Split, By End User
           7.3.5 Cell Analyzers
                    7.3.5.1 Flow Cytometry Based Cell Analyzers Market Split, By Application
                    7.3.5.2 Flow Cytometry Based Cell Analyzers Market Split, By Research Application
                    7.3.5.3 Flow Cytometry Based Cell Analyzers Market Split, By Clinical Application
                    7.3.5.4 Flow Cytometry Based Cell Analyzers Market Split, By End User
                    7.3.5.5 High-Range Cell Analyzers
                               7.3.5.5.1 High-Range Cell Analyzers Account for the Largest Share of the Cell Analyzers Market
                    7.3.5.6 Mid-Range Cell Analyzers
                               7.3.5.6.1 Wide Availability of Compact and High-Performance Analyzers in This Price Range Support Market Growth
                    7.3.5.7 Low-Range Cell Analyzers
                               7.3.5.7.1 Low-Range Analyzers Find Significant Adoption Among Price-Sensitive End Users
           7.3.6 Cell Sorters
                    7.3.6.1 Flow Cytometry Based Cell Sorters Market Split, By Application
                    7.3.6.2 Flow Cytometry Based Cell Sorters Market Split, By Research Application
                    7.3.6.3 Flow Cytometry Based Cell Sorters Market Split, By Clinical Application
                    7.3.6.4 Flow Cytometry Based Cell Sorters Market Split, By End User
                    7.3.6.5 High-Range Cell Sorters
                               7.3.6.5.1 High-Range Cell Sorters Dominate the Market
                    7.3.6.6 Mid-Range Cell Sorters
                               7.3.6.6.1 Product Launches and A Balance Between Efficiency and Costs Have Enabled the Growth of This Market Segment
                    7.3.6.7 Low-Range Cell Sorters
                               7.3.6.7.1 Increasing Commercialization of Affordable Products has Driven Adoption of Low-Range Cell Sorters
    7.4 Services
           7.4.1 Flow Cytometry Services Market Split, By Application
           7.4.2 Flow Cytometry Services Market Split, By Research Application
           7.4.3 Flow Cytometry Services Market Split, By Clinical Application
           7.4.4 Flow Cytometry Services Market Split, By End User
    7.5 Software
           7.5.1 Flow Cytometry Software Market Split, By Application
           7.5.2 Flow Cytometry Software Market Split, By Research Application
           7.5.3 Flow Cytometry Software Market Split, By Clinical Application
           7.5.4 Flow Cytometry Software Market Split, By End User
    7.6 Accessories
           7.6.1 Flow Cytometry Accessories Market Split, By Application
           7.6.2 Flow Cytometry Accessories Market Split, By Research Application
           7.6.3 Flow Cytometry Accessories Market Split, By Clinical Application
           7.6.4 Flow Cytometry Accessories Market Split, By End User

8 Flow Cytometry Market, By Application (Page No. - 94)
    8.1 Introduction
    8.2 Research Applications
           8.2.1 Pharmaceuticals & Biotechnology
                    8.2.1.1 Drug Discovery
                               8.2.1.1.1 Wide Usage of Flow Cytometry in Drug Discovery is the Primary Driver of Market Growth
                    8.2.1.2 Stem Cell Research
                               8.2.1.2.1 Accuracy and Precision of Flow Cytometry Have Made It A Prominent Tool in Stem Cell Research
                    8.2.1.3 in Vitro Toxicity Testing
                               8.2.1.3.1 Need to Reduce Time and Cost of Drug Development Processes Will Be A Key Factor Driving Market Growth
           8.2.2 Immunology
                    8.2.2.1 Flow Cytometry Plays A Vital Role in Immunology Studies
           8.2.3 Cell Sorting
                    8.2.3.1 The Increase in Cell-Based Research Activity has Boosted Growth in This Application Segment
           8.2.4 Apoptosis
                    8.2.4.1 Flow Cytometry Techniques are Used to Identify Changes Occurring During Apoptosis
           8.2.5 Cell Cycle Analysis
                    8.2.5.1 Any Abnormality in Dna Content Can Be Detected Using Flow Cytometry
           8.2.6 Cell Viability
                    8.2.6.1 Cell Viability is A Key Parameter Studied Using Flow Cytometry
           8.2.7 Cell Counting
                    8.2.7.1 Flow Cytometry Allows for Easy Differentiation of Cells Via Scattering Or Staining
           8.2.8 Other Research Applications
    8.3 Clinical Applications
           8.3.1 Cancer
                    8.3.1.1 Cancer Applications Include Determination of Tumor Malignancy and Chromosome Enumeration
           8.3.2 Hematology
                    8.3.2.1 Flow Cytometry Can Help Identify A Wide Variety of Cell Surfaces and Cytoplasmic Antigens
           8.3.3 Immunodeficiency Diseases
                    8.3.3.1 Flow Cytometry Allows for Simultaneous, Multi-Parameter Cell Analysis
           8.3.4 Organ Transplantation
                    8.3.4.1 Use of Flow Cytometry to Reduce Organ Rejection Rates has Contributed to Market Growth
           8.3.5 Other Clinical Applications
    8.4 Industrial Applications
           8.4.1 Wide End User Base to Drive Industrial Application Market Growth

9 Flow Cytometry Market, By End User (Page No. - 117)
    9.1 Introduction
    9.2 Academic and Research Institutes
           9.2.1 Strengthening Research Pipeline and Industry-Academia Collaboration to Drive the Market Growth
    9.3 Hospitals & Clinical Testing Laboratories
           9.3.1 Rising Awareness and Disease Prevalence Have Sustained the Demand for Flow Cytometry
    9.4 Pharmaceutical & Biotechnology Companies
           9.4.1 Growing Drug Discovery Activity to Drive Market Growth

10 Flow Cytometry Market, By Region (Page No. - 123)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 High Adoption of Advanced Flow Cytometry Products Among End Users to Drive Market Growth in the Us
             10.2.2 Canada
                        10.2.2.1 Availability of Public and Private Funding for Research Activities to Boost the Demand for Flow Cytometry Products in Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Greater Outsourcing of Clinical Diagnostic Services to Be the Key Trend in the German Flow Cytometry Market
             10.3.2 UK
                        10.3.2.1 UK to Witness Growing Acceptance of Flow Cytometry Products for Clinical Diagnostics
             10.3.3 France
                        10.3.3.1 Training and Awareness Programs By Social Organizations and Key Players Expected to Fuel the Adoption of Flow Cytometry
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
                        10.4.1.1 Strong Infrastructure and Favorable Market Outlook Have Sustained Japan’s Dominance in the APAC Market
             10.4.2 China
                        10.4.2.1 China Accounts for the Second-Largest Share in the APAC Market
             10.4.3 India
                        10.4.3.1 High Incidence of Hiv/Aids and Cancer to Drive the Demand for Flow Cytometry Instruments in India
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
             10.5.1 Brazil
                        10.5.1.1 Brazil Dominates the Latam Market for Flow Cytometry
             10.5.2 Mexico
                        10.5.2.1 Free Trade Agreements Will Support Imports, Accessibility to Flow Cytometry Instruments in Mexico
             10.5.3 Rest of Latin America
     10.6 Middle East and Africa
             10.6.1 Low Disposable Income and Need for Infrastructural Development Hinder Market Growth

11 Competitive Landscape (Page No. - 173)
     11.1 Overview
     11.2 Global Market Share Analysis (2017)
     11.3 Competitive Scenario
             11.3.1 Key Product Launches and Approvals (2015–2018)
             11.3.2 Key Agreements, Partnerships, and Collaborations (2015–2018)
             11.3.3 Key Acquisitions (2015–2018)
             11.3.4 Key Expansions (2015–2018)
     11.4 Competitive Leadership Mapping
             11.4.1 Competitive Leadership Mapping: Major Market Players (2017)
                        11.4.1.1 Vanguards
                        11.4.1.2 Innovators
                        11.4.1.3 Dynamic Players
                        11.4.1.4 Emerging Companies
             11.4.2 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-UPS (2017)
                        11.4.2.1 Progressive Companies
                        11.4.2.2 Starting Blocks
                        11.4.2.3 Responsive Companies
                        11.4.2.4 Dynamic Companies

12 Company Profiles (Page No. - 181)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Agilent Technologies
     12.2 Apogee Flow Systems
     12.3 Beckman Coulter (A Subsidiary of Danaher)
     12.4 Becton, Dickinson and Company
     12.5 Biomιrieux S.A.
     12.6 Bio-Rad Laboratories
     12.7 Cytonome St
     12.8 Enzo Life Sciences (A Wholly Owned Subsidiary of Enzo Biochem, Inc.)
     12.9 Luminex
     12.10 Merck KGaA
     12.11 Miltenyi Biotec
     12.12 Sony Biotechnology (A Wholly Owned Subsidiary of Sony Corporation of America)
     12.13 Stratedigm
     12.14 Sysmex Partec (A Subsidiary of Sysmex Corporation)
     12.15 Thermo Fisher Scientific

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 226)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (181 Tables)

Table 1 Incidence of Hiv/Aids, By Region, 2017
Table 2 Cancer Incidence and Prevalence Data, By Country, 2018
Table 3 Market, By Technology, 2016–2023 (USD Million)
Table 4 Cell-Based Market, By Region, 2016–2023 (USD Million)
Table 5 Bead-Based Market, By Region, 2016–2023 (USD Million)
Table 6 Market, By Product & Service, 2016–2023 (USD Million)
Table 7 Flow Cytometry Reagents and Consumables Market, By Application, 2016–2023 (USD Million)
Table 8 Flow Cytometry Reagents and Consumables Market, By Research Application, 2016–2023 (USD Million)
Table 9 Flow Cytometry Reagents and Consumables Market, By Clinical Application, 2016–2023 (USD Million)
Table 10 Flow Cytometry Reagents and Consumables Market, By End Users, 2016–2023 (USD Million)
Table 11 Flow Cytometry Reagents and Consumables Market, By Region, 2016–2023 (USD Million)
Table 12 Flow Cytometry Instruments Market, By Type, 2016–2023 (USD Million)
Table 13 Flow Cytometry Instruments Market, By Product, 2016–2023 (Units)
Table 14 Flow Cytometry Instruments Market, By Application, 2016–2023 (USD Million)
Table 15 Flow Cytometry Instruments Market, By Research Application, 2016–2023 (USD Million)
Table 16 Flow Cytometry Instruments Market, By Clinical Application, 2016–2023 (USD Million)
Table 17 Flow Cytometry Instruments Market, By End Users, 2016–2023 (USD Million)
Table 18 Flow Cytometry Instruments Market, By Region, 2016–2023 (USD Million)
Table 19 Flow Cytometry Instruments Market, By Region, 2016–2023 (Units)
Table 20 Flow Cytometry Based Cell Analyzers Market, By Price Range, 2016–2023 (USD Million)
Table 21 Flow Cytometry Based Cell Analyzers Market, By Application, 2016–2023 (USD Million)
Table 22 Flow Cytometry Based Cell Analyzers Market, By Research Application, 2016–2023 (USD Million)
Table 23 Flow Cytometry Based Cell Analyzers Market, By Clinical Application, 2016–2023 (USD Million)
Table 24 Flow Cytometry Based Cell Analyzers Market, By End Users, 2016–2023 (USD Million)
Table 25 Flow Cytometry Based Cell Analyzers Market, By Region, 2016–2023 (USD Million)
Table 26 Flow Cytometry Based Cell Analyzers Market, By Region, 2016–2023 (Units)
Table 27 High-Range Cell Analyzers Market, By Region, 2016–2023 (USD Million)-
Table 28 Mid-Range Cell Analyzers Market, By Region, 2016–2023 (USD Million)
Table 29 Low-Range Cell Analyzers Market, By Region, 2016–2023 (USD Million)
Table 30 Flow Cytometry Based Cell Sorters Market, By Price Range, 2016–2023 (USD Million)
Table 31 Flow Cytometry Based Cell Sorters Market, By Application, 2016–2023 (USD Million)
Table 32 Flow Cytometry Based Cell Sorters Market, By Research Application, 2016–2023 (USD Million)
Table 33 Flow Cytometry Based Cell Sorters Market, By Clinical Application, 2016–2023 (USD Million)
Table 34 Flow Cytometry Based Cell Sorters Market, By End Users, 2016–2023 (USD Million)
Table 35 Flow Cytometry Based Cell Sorters Market, By Region, 2016–2023 (USD Million)
Table 36 Flow Cytometry Based Cell Sorters Market, By Region, 2016–2023 (Units)
Table 37 High-Range Cell Sorters Market, By Region, 2016–2023 (USD Million)
Table 38 Mid-Range Cell Sorters Market, By Region, 2016–2023 (USD Million)
Table 39 Low-Range Cell Sorters Market, By Region, 2016–2023 (USD Million)
Table 40 Flow Cytometry Services Market, By Application, 2016–2023 (USD Million)
Table 41 Flow Cytometry Services Market, By Research Application, 2016–2023 (USD Million)
Table 42 Flow Cytometry Services Market, By Clinical Application, 2016–2023 (USD Million)
Table 43 Flow Cytometry Services Market, By End Users, 2016–2023 (USD Million)
Table 44 Flow Cytometry Services Market, By Region, 2016–2023 (USD Million)
Table 45 Flow Cytometry Software Market, By Application, 2016–2023 (USD Million)
Table 46 Flow Cytometry Software Market, By Research Application, 2016–2023 (USD Million)
Table 47 Flow Cytometry Software Market, By Clinical Application, 2016–2023 (USD Million)
Table 48 Flow Cytometry Software Market, By End Users, 2016–2023 (USD Million)
Table 49 Flow Cytometry Software Market, By Region, 2016–2023 (USD Million)
Table 50 Flow Cytometry Accessories Market, By Application, 2016–2023 (USD Million)
Table 51 Flow Cytometry Accessories Market, By Research Application, 2016–2023 (USD Million)
Table 52 Flow Cytometry Accessories Market, By Clinical Application, 2016–2023 (USD Million)
Table 53 Flow Cytometry Accessories Market, By End Users, 2016–2023 (USD Million)
Table 54 Flow Cytometry Accessories Market, By Region, 2016–2023 (USD Million)
Table 55 Flow Cytometry Market, By Application, 2016–2023 (USD Million)
Table 56 Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 57 Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 58 Market for Pharmaceutical and Biotechnology Applications, By Type, 2016–2023 (USD Million)
Table 59 Market for Pharmaceutical and Biotechnology Applications, By Region, 2016–2023 (USD Million)
Table 60 Market for Drug Discovery Applications, By Region, 2016–2023 (USD Million)
Table 61 Market for Stem Cell Research Applications, By Region, 2016–2023 (USD Million)
Table 62 Market for in Vitro Toxicity Testing Applications, By Region, 2016–2023 (USD Million)
Table 63 Market for Immunology Applications, By Region, 2016–2023 (USD Million)
Table 64 Market for Cell Sorting Applications, By Region, 2016–2023 (USD Million)
Table 65 Market for Apoptosis Applications, By Region, 2016–2023 (USD Million)
Table 66 Market for Cell Cycle Analysis Applications, By Region, 2016–2023 (USD Million)
Table 67 Flow Cytometry Market for Cell Viability Applications, By Region, 2016–2023 (USD Million)
Table 68 Market for Cell Counting Applications, By Region, 2016–2023 (USD Million)
Table 69 Market for Other Research Applications, By Region, 2016–2023 (USD Million)
Table 70 Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 71 Market for Clinical Applications, By Region, 2016–2023 (USD Million)
Table 72 Market for Cancer Applications, By Region, 2016–2023 (USD Million)
Table 73 Market for Hematology Applications, By Region, 2016–2023 (USD Million)
Table 74 Market for Immunodeficiency Disease Applications, By Region, 2016–2023 (USD Million)
Table 75 Market for Organ Transplantation Applications, By Region, 2016–2023 (USD Million)
Table 76 Market for Other Clinical Applications, By Region, 2016–2023 (USD Million)
Table 77 Market for Industrial Applications, By Region, 2016–2023 (USD Million)
Table 78 Market, By End User, 2016–2023 (USD Million)
Table 79 Market for Academic & Research Institutes, By Region, 2016–2023 (USD Million)
Table 80 Flow Cytometry Market for Hospitals & Clinical Testing Laboratories, By Region, 2016–2023 (USD Million)
Table 81 Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 82 Market, By Region, 2016–2023 (USD Million)
Table 83 North America: Market, By Country, 2016–2023 (USD Million)
Table 84 North America: Market, By Product & Service, 2016–2023 (USD Million)
Table 85 North America: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 86 North America: Flow Cytometry Instruments Market, By Product, 2016–2023 (Units)
Table 87 North America: Flow Cytometry Market, By Technology, 2016–2023 (USD Million)
Table 88 North America: Market, By Application, 2016–2023 (USD Million)
Table 89 North America: Market, By End User, 2016–2023 (USD Million)
Table 90 US: Market, By Product & Service, 2016–2023 (USD Million)
Table 91 US: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 92 US: Market, By Technology, 2016–2023 (USD Million)
Table 93 US: Market, By Application, 2016–2023 (USD Million)
Table 94 US: Market, By End User, 2016–2023 (USD Million)
Table 95 Canada: Market, By Product & Service, 2016–2023 (USD Million)
Table 96 Canada: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 97 Canada: Market, By Technology, 2016–2023 (USD Million)
Table 98 Canada: Market, By Application, 2016–2023 (USD Million)
Table 99 Canada: Market, By End User, 2016–2023 (USD Million)
Table 100 Europe: Market, By Country, 2016–2023 (USD Million)
Table 101 Europe: Market, By Product & Service, 2016–2023 (USD Million)
Table 102 Europe: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 103 Europe: Flow Cytometry Instruments Market, By Product, 2016–2023 (Units)
Table 104 Europe: Market, By Technology, 2016–2023 (USD Million)
Table 105 Europe: Market, By Application, 2016–2023 (USD Million)
Table 106 Europe: Market, By End User, 2016–2023 (USD Million)
Table 107 Germany: Market, By Product & Service, 2016–2023 (USD Million)
Table 108 Germany: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 109 Germany: Market, By Technology, 2016–2023 (USD Million)
Table 110 Germany: Market, By Application, 2016–2023 (USD Million)
Table 111 Germany: Flow Cytometry Market, By End User, 2016–2023 (USD Million)
Table 112 UK: Market, By Product & Service, 2016–2023 (USD Million)
Table 113 UK: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 114 UK: Market, By Technology, 2016–2023 (USD Million)
Table 115 UK: Market, By Application, 2016–2023 (USD Million)
Table 116 UK: Market, By End User, 2016–2023 (USD Million)
Table 117 France: Market, By Product & Service, 2016–2023 (USD Million)
Table 118 France: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 119 France: Market, By Technology, 2016–2023 (USD Million)
Table 120 France: Market, By Application, 2016–2023 (USD Million)
Table 121 France: Market, By End User, 2016–2023 (USD Million)
Table 122 Rest of Europe: Flow Cytometry Market, By Product & Service, 2016–2023 (USD Million)
Table 123 Rest of Europe: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 124 Rest of Europe: Market, By Technology, 2016–2023 (USD Million)
Table 125 Rest of Europe: Market, By Application, 2016–2023 (USD Million)
Table 126 Rest of Europe: Market, By End User, 2016–2023 (USD Million)
Table 127 APAC: Market, By Country, 2016–2023 (USD Million)
Table 128 Asia Pacific: Market, By Product & Service, 2016–2023 (USD Million)
Table 129 Asia Pacific: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 130 Asia Pacific: Flow Cytometry Instruments Market, By Product, 2016–2023 (Units)
Table 131 Asia Pacific: Market, By Technology, 2016–2023 (USD Million)
Table 132 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 133 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 134 Japan: Market, By Product & Service, 2016–2023 (USD Million)
Table 135 Japan: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 136 Japan: Market, By Technology, 2016–2023 (USD Million)
Table 137 Japan: Market, By Application, 2016–2023 (USD Million)
Table 138 Japan: Market, By End User, 2016–2023 (USD Million)
Table 139 China: Market, By Product & Service, 2016–2023 (USD Million)
Table 140 China: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 141 China: Market, By Technology, 2016–2023 (USD Million)
Table 142 China: Market, By Application, 2016–2023 (USD Million)
Table 143 China: Market, By End User, 2016–2023 (USD Million)
Table 144 India: Market, By Product & Service, 2016–2023 (USD Million)
Table 145 India: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 146 India: Flow Cytometry Market, By Technology, 2016–2023 (USD Million)
Table 147 India: Market, By Application, 2016–2023 (USD Million)
Table 148 India: Market, By End User, 2016–2023 (USD Million)
Table 149 RoAPAC: Market, By Product & Service, 2016–2023 (USD Million)
Table 150 RoAPAC: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 151 RoAPAC: Market, By Technology, 2016–2023 (USD Million)
Table 152 RoAPAC: Market, By Application, 2016–2023 (USD Million)
Table 153 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 154 Latin America: Market, By Country, 2016–2023 (USD Million)
Table 155 Latin America: Market, By Product & Service, 2016–2023 (USD Million)
Table 156 Latin America: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 157 Latin America: Flow Cytometry Instruments Market, By Product, 2016–2023 (Units)
Table 158 Latin America: Flow Cytometry Market, By Technology, 2016–2023 (USD Million)
Table 159 Latin America: Market, By Application, 2016–2023 (USD Million)
Table 160 Latin America: Market, By End User, 2016–2023 (USD Million)
Table 161 Brazil: Market, By Product & Service, 2016–2023 (USD Million)
Table 162 Brazil: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 163 Brazil: Market, By Technology, 2016–2023 (USD Million)
Table 164 Brazil: Market, By Application, 2016–2023 (USD Million)
Table 165 Brazil: Market, By End User, 2016–2023 (USD Million)
Table 166 Mexico: Market, By Product & Service, 2016–2023 (USD Million)
Table 167 Mexico: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 168 Mexico: Flow Cytometry Market, By Technology, 2016–2023 (USD Million)
Table 169 Mexico: Market, By Application, 2016–2023 (USD Million)
Table 170 Mexico: Market, By End User, 2016–2023 (USD Million)
Table 171 RoLA: Market, By Product & Service, 2016–2023 (USD Million)
Table 172 RoLA: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 173 RoLA: Market, By Technology, 2016–2023 (USD Million)
Table 174 RoLA: Market, By Application, 2016–2023 (USD Million)
Table 175 RoLA: Market, By End User, 2016–2023 (USD Million)
Table 176 Middle East and Africa: Market, By Product & Service, 2016–2023 (USD Million)
Table 177 Middle East and Africa: Flow Cytometry Instruments Market, By Product, 2016–2023 (USD Million)
Table 178 Middle East and Africa: Flow Cytometry Instruments Market, By Product, 2016–2023 (Units)
Table 179 Middle East and Africa: Market, By Technology, 2016–2023 (USD Million)
Table 180 Middle East and Africa: Market, By Application, 2016–2023 (USD Million)
Table 181 Middle East and Africa: Flow Cytometry Market, By End User, 2016–2023 (USD Million)


List of Figures (38 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Flow Cytometry Market
Figure 5 Global Market: Data Triangulation
Figure 6 Market, By Technology, 2018 vs 2023 (USD Million)
Figure 7 Market, By Product & Service, 2018 vs 2023 (USD Million)
Figure 8 Market, By Application, 2018 vs 2023 (USD Million)
Figure 9 Market, By End User, 2018 vs 2023 (USD Million)
Figure 10 Geographic Snapshot of the Market
Figure 11 Ongoing Technological Advancements and Greater Adoption Among Researchers & Academia to Drive the Overall Market Growth
Figure 12 Reagents and Consumables to Account for the Largest Market Share Till 2023
Figure 13 Research Applications Will Continue to Dominate the Global Flow Cytometry Market in 2023
Figure 14 Hospitals and Clinical Testing Laboratories to Account for the Largest Market Share in 2023
Figure 15 Asia Pacific to Witness the Highest CAGR During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Cell-Based Flow Cytometry Segment Will Continue to Dominate the Flow Cytometry Market in 2023
Figure 18 Reagents and Consumables Segment to Dominate the Market in 2018
Figure 19 Clinical Applications Poised to Be the Fastest Growing Segment During the Forecast Period
Figure 20 Hospitals & Clinical Testing Laboratories to Witness the Highest Revenue Growth During the Forecast Period
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia Pacific: Market Snapshot
Figure 24 Key Developments By Leading Market Players in the Flow Cytometry Market, 2015–2018
Figure 25 Global Market Share Analysis, By Top 3 Players (2017)
Figure 26 Competitive Leadership Mapping (Overall Market)
Figure 27 Competitive Leadership Mapping (SME/Start-UPS)
Figure 28 Agilent Technologies: Company Snapshot (2017)
Figure 29 Danaher: Company Snapshot (2017)
Figure 30 Becton, Dickinson and Company: Company Snapshot (2018)
Figure 31 Biomιrieux S.A.: Company Snapshot (2017)
Figure 32 Bio-Rad Laboratories: Company Snapshot (2017)
Figure 33 Enzo Biochem, Inc.: Company Snapshot (2017)
Figure 34 Luminex: Company Snapshot (2017)
Figure 35 Merck KGaA: Company Snapshot (2017)
Figure 36 Sony Corporation: Company Snapshot (2017)
Figure 37 Sysmex Corporation: Company Snapshot (2017)
Figure 38 Thermo Fisher Scientific: Company Snapshot (2017)

To get more details on this report, Request FREE Sample

This research study involved four major activities to estimate the current market size for flow cytometry products and services. Exhaustive secondary research was done to collect information on the market and subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

The flow cytometry market comprises several stakeholders such as flow cytometry product manufacturers, suppliers and distributors, healthcare service providers, and academic and research institutes. The demand side of this market is characterized by the growing demand for compact, high-throughput, and affordable flow cytometry instruments. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. A breakdown of primary respondents follows:

Flow Cytometry Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the flow cytometry market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the flow cytometry industry.

Report Objectives

  • To define, describe, and forecast the global flow cytometry market on the basis of technology, product and service, application, end user, and region
  • To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global flow cytometry market
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the global flow cytometry market
  • To analyze opportunities in the global flow cytometry market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the global flow cytometry market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, agreements, partnerships, collaborations, acquisitions, and expansions in the global flow cytometry market     

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the client’s specific needs. The following customization options are available for the present global flow cytometry market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the flow cytometry market

Company Information

  • Detailed analysis and profiling of additional market companies (up to five)
Report Code
BT 6015
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Flow Cytometry Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home